A study examining 1031 hospitalized COVID-19 patients found that aging significantly impacts immune responses, viral dynamics, and the nasal microbiome, with older adults experiencing more severe disease symptoms and delayed viral clearance.
Large-scale study found that long COVID patients exhibit sustained inflammation and specific immune responses associated with varying symptoms, highlighting the importance of personalized treatment approaches.
Scientists have found success in treating an arguably neglected inflammatory condition, polymyalgia rheumatica, with a drug that could provide an alternative to steroids for patients.